Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis

Hemophagocytic lymphohistiocytosis (HLH) is an often-fatal disorder characterized by the overactivation of T cells and macrophages that excessively produce proinflammatory cytokines, including interferon-γ (IFN-γ). Previously, we reported that the JAK inhibitor ruxolitinib dampens T-cell activation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Albeituni, Sabrin, Verbist, Katherine C., Tedrick, Paige E., Tillman, Heather, Picarsic, Jennifer, Bassett, Rachel, Nichols, Kim E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Immunobiology and Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6624972/
https://ncbi.nlm.nih.gov/pubmed/31015190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados